The Shigella flexneri serotype Y vaccine candidate SFL124 originated from a serotype 2a background

Fleur Roberts, Amy V. Jennison, Naresh K. Verma*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    10 Citations (Scopus)

    Abstract

    Shigella flexneri is endemic in most developing countries and responsible for the highest mortality rate among the Shigella species. The attenuated serotype Y S. flexneri strain SFL124 has been used as the parental strain for the development of recombinant vaccines expressing multiple O-antigen structures. During the development of one such multivalent vaccine, a region of gtrII homology was found in SFL124. Sequencing and analysis of this region revealed the presence of an insertion element interrupted serotype 2a serotype-conversion locus in the serotype Y vaccine strain SFL124. The data presented suggests that SFL124 has derived from a serotype 2a background.

    Original languageEnglish
    Pages (from-to)285-289
    Number of pages5
    JournalFEMS Immunology and Medical Microbiology
    Volume45
    Issue number2
    DOIs
    Publication statusPublished - 1 Aug 2005

    Fingerprint

    Dive into the research topics of 'The Shigella flexneri serotype Y vaccine candidate SFL124 originated from a serotype 2a background'. Together they form a unique fingerprint.

    Cite this